Erica O. Saphire, Ph.D.
Affiliations: | 2000 | Scripps Research Institute, La Jolla, La Jolla, CA, United States |
Area:
Structural biology, immunology, X-ray crystallographyGoogle:
"Erica Saphire"Mean distance: 9.37 | S | N | B | C | P |
Parents
Sign in to add mentorIan A. Wilson | grad student | 2000 | Scripps Institute | |
(Crystal structure of an intact human IgG: Implications for HIV -1 neutralization and effector function.) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Saphire E, Salie ZL, Ke Z, et al. (2023) Anti-Ebola virus mAb 3A6 with unprecedented potency protects highly viremic animals from fatal outcome and physically lifts its glycoprotein target from the virion membrane. Research Square |
Olmedillas E, Rajamanickam RR, Avalos RD, et al. (2023) Structure of a SARS-CoV-2 spike S2 subunit in a pre-fusion, open conformation. Biorxiv : the Preprint Server For Biology |
Yu X, Hastie KM, Davis CW, et al. (2023) The evolution and determinants of neutralization of potent head-binding antibodies against Ebola virus. Cell Reports. 42: 113366 |
Streblow DN, Hirsch AJ, Stanton JJ, et al. (2023) Aerosol delivery of SARS-CoV-2 human monoclonal antibodies in macaques limits viral replication and lung pathology. Nature Communications. 14: 7062 |
Ronk AJ, Lloyd NM, Zhang M, et al. (2023) A Lassa virus mRNA vaccine confers protection but does not require neutralizing antibody in a guinea pig model of infection. Nature Communications. 14: 5603 |
Fang J, Castillon G, Phan S, et al. (2023) Spatial and functional arrangement of Ebola virus polymerase inside phase-separated viral factories. Nature Communications. 14: 4159 |
Kaplonek P, Cizmeci D, Kwatra G, et al. (2023) ChAdOx1 nCoV-19 (AZD1222) vaccine-induced Fc receptor binding tracks with differential susceptibility to COVID-19. Nature Immunology |
Hastie KM, Yu X, Ana-Sosa-Batiz F, et al. (2023) Potent Omicron-neutralizing antibodies isolated from a patient vaccinated 6 months before Omicron emergence. Cell Reports. 42: 112421 |
Gunn BM, McNamara RP, Wood L, et al. (2023) Antibodies against the Ebola virus soluble glycoprotein are associated with long-term vaccine-mediated protection of non-human primates. Cell Reports. 42: 112402 |
Chen EC, Gilchuk P, Zost SJ, et al. (2023) Systematic analysis of human antibody response to ebolavirus glycoprotein shows high prevalence of neutralizing public clonotypes. Cell Reports. 42: 112370 |